Robert J. Arceci, MD, PhD
Articles by Robert J. Arceci, MD, PhD
Radiotherapy in the Modern Era in the Management of Langerhans Cell Histiocytosis
ByRupen Garg, BS,Qinyu Chen, MHS,Yin Zhang, PhD,Ariel E. Marciscano, MD,Jing Zeng, MD,Robert J. Arceci, MD, PhD,Stephanie A. Terezakis, MD Intensity-modulated radiotherapy reduces the mean radiation dose delivered to critical normal structures and should be considered in Langerhans cell histiocytosis treatment when radiotherapy is indicated, particularly given the expected, long-term survival of these patients.
